The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T’N’T HepC)
Introduction Injecting drug use is the primary driver of hepatitis C virus (HCV) infection in Europe. Despite the need for more engagement with care, people who inject drugs (PWID) are hard to reach with HCV testing and treatment. We initiated a study to evaluate the efficacy for testing and linkage...
Saved in:
| Main Authors: | Nina Weis, Jeffrey Victor Lazarus, Anne Øvrehus, Jonas Demant, Louise Krohn-Dehli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/11/e039724.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment
by: Paul Damien James, et al.
Published: (2012-01-01) -
TnT: T Antigen and Telomerase, an Explosive Route to Cancer
by: F. Andrew Ray
Published: (2008-01-01) -
Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO)
by: Alexander Egeberg, et al.
Published: (2020-08-01) -
Impact of TNT explosive and its degradation products on the environment
by: Vanja Trifunović, et al.
Published: (2019-06-01) -
Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
by: Fatih Mehmet Akıllı
Published: (2024-12-01)